Combined modality therapy with radiation therapy (RT), chemotherapy, bevacizumab, and erlotinib in the treatment of patients (pts) with locally advanced squamous carcinoma of the head and neck

A. A. Meluch,David R. Spigel,H. A. Burris,Cassie M. Lane,J. D. Peyton,Dianna Shipley,Mark S. Rubin,Michael Stipanov,F. A. Greco,John D. Hainsworth

Combined modality therapy with radiation therapy (RT), chemotherapy, bevacizumab, and erlotinib in the treatment of patients (pts) with locally advanced squamous carcinoma of the head and neck

2016

A. A. Meluch
David R. Spigel
H. A. Burris
Cassie M. Lane
J. D. Peyton
Dianna Shipley
Mark S. Rubin
Michael Stipanov
F. A. Greco
John D. Hainsworth

6012 Background: Concurrent chemotherapy/RT is the standard of treatment for locally advanced head and neck cancer. Agents targeting EGFR and the angiogenesis pathway have also demonstrated activit...

Keywords:

Carcinoma
Bevacizumab
Erlotinib
Pathology
Combined Modality Therapy
Oncology
Angiogenesis Pathway
Head and neck cancer
Radiation therapy
Medicine
Internal medicine
Chemotherapy
locally advanced
squamous carcinoma

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations